OBJECTIVE: The objective of the study was to evaluate the efficacy and tolerability of trimethoprim-sulfamethoxazole (also known as co-trimoxazole, TMPS) to treat Klebsiella pneumoniae (Kp)-K. pneumoniae carbapenemase (KPC) infections. METHODS: Clinical data of patients with a TMPS-susceptible Kp-KPC infection were collected as a case series. RESULTS: We report clinical outcomes and tolerability for 14 patients infected by Kp-KPC strains susceptible to TMPS, including three bloodstream infections. In ten cases (71.4%), TMPS was administered as monotherapy. In all but one case, Kp-KPC infection was cured. In the remaining patient, therapy was discontinued because of an adverse event. CONCLUSIONS: The use of TMPS to treat TMPS-susceptible Kp-KPC infections seems promising.
OBJECTIVE: The objective of the study was to evaluate the efficacy and tolerability of trimethoprim-sulfamethoxazole (also known as co-trimoxazole, TMPS) to treat Klebsiella pneumoniae (Kp)-K. pneumoniae carbapenemase (KPC) infections. METHODS: Clinical data of patients with a TMPS-susceptible Kp-KPC infection were collected as a case series. RESULTS: We report clinical outcomes and tolerability for 14 patients infected by Kp-KPC strains susceptible to TMPS, including three bloodstream infections. In ten cases (71.4%), TMPS was administered as monotherapy. In all but one case, Kp-KPC infection was cured. In the remaining patient, therapy was discontinued because of an adverse event. CONCLUSIONS: The use of TMPS to treat TMPS-susceptible Kp-KPC infections seems promising.
Authors: Antonio T Freire; Vasyl Melnyk; Min Ja Kim; Oleksiy Datsenko; Oleksandr Dzyublik; Felix Glumcher; Yin-Ching Chuang; Robert T Maroko; Gary Dukart; C Angel Cooper; Joan M Korth-Bradley; Nathalie Dartois; Hassan Gandjini Journal: Diagn Microbiol Infect Dis Date: 2010-10 Impact factor: 2.803
Authors: Jesús Oteo; Adriana Ortega; Rosa Bartolomé; Germán Bou; Carmen Conejo; Marta Fernández-Martínez; Juan José González-López; Laura Martínez-García; Luis Martínez-Martínez; María Merino; Elisenda Miró; Marta Mora; Ferran Navarro; Antonio Oliver; Álvaro Pascual; Jesús Rodríguez-Baño; Guillermo Ruiz-Carrascoso; Patricia Ruiz-Garbajosa; Laura Zamorano; Verónica Bautista; María Pérez-Vázquez; José Campos Journal: Antimicrob Agents Chemother Date: 2015-03-30 Impact factor: 5.191
Authors: Zubair A Qureshi; David L Paterson; Brian A Potoski; Mary C Kilayko; Gabriel Sandovsky; Emilia Sordillo; Bruce Polsky; Jennifer M Adams-Haduch; Yohei Doi Journal: Antimicrob Agents Chemother Date: 2012-01-17 Impact factor: 5.191
Authors: Elizabeth A Neuner; Jun-Yen Yeh; Gerri S Hall; Jennifer Sekeres; Andrea Endimiani; Robert A Bonomo; Nabin K Shrestha; Thomas G Fraser; David van Duin Journal: Diagn Microbiol Infect Dis Date: 2011-04 Impact factor: 2.803
Authors: Derek N Bremmer; Cornelius J Clancy; Ellen G Press; Reem Almaghrabi; Liang Chen; Yohei Doi; M Hong Nguyen; Ryan K Shields Journal: Antimicrob Agents Chemother Date: 2014-10-06 Impact factor: 5.191
Authors: H C Maltezou; P Giakkoupi; A Maragos; M Bolikas; V Raftopoulos; H Papahatzaki; G Vrouhos; V Liakou; A C Vatopoulos Journal: J Infect Date: 2009-02-26 Impact factor: 6.072
Authors: Fortunata Lombardi; Paola Gaia; Rea Valaperta; Maria Cornetta; Milvana Rosa Tejada; Luca Di Girolamo; Alessandra Moroni; Federica Ramundo; Alessio Colombo; Massimiliano Valisi; Elena Costa Journal: Biomed Res Int Date: 2015-05-04 Impact factor: 3.411